Clinical Trials Logo

Tumors Metastatic to Brain clinical trials

View clinical trials related to Tumors Metastatic to Brain.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02107755 Active, not recruiting - Liver Metastases Clinical Trials

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Start date: July 2, 2014
Phase: Phase 2
Study type: Interventional

This phase II trial studies the effectiveness of the combination of stereotactic radiation therapy and ipilimumab in patients with metastatic melanoma that has spread to four or fewer sites in the body (oligometastatic). Stereotactic radiation therapy is a type of external beam radiation therapy that uses special equipment to position the patient and precisely give a either a single large dose of radiation therapy to a tumor or several large doses of radiation therapy to a tumor using precision and accuracy that is guided by onboard daily imaging prior to radiation therapy. Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some monoclonal antibodies find tumor cells and help kill them or carry tumor-killing substances to them. Giving stereotactic radiosurgery together with ipilimumab may kill more tumor cells by causing addition melanoma antigens to be presented to the immune system.

NCT ID: NCT01706432 Active, not recruiting - Liver Metastases Clinical Trials

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Start date: June 15, 2009
Phase:
Study type: Observational

This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.